Endo Health: Top-line data show the
investigational TOPAS system improves fecal incontinence in women (ENDP)
Rocket Fuel announces CFO
transition and reaffirms prior guidance for the 3Q14 and FY14 (FUEL)
iPass to explore strategic
alternatives (IPAS)
CI Building Systems beats by $0.02,
beats on revs (NCS)
Allison Transmission and EnerDel
enter into strategic relationship naming the battery manufacturer's
PP320-689-LP Vigor+ pack as approved Allison support equipment (ALSN)
Chimerix's Brincidofovir suggests
favorable resistance profile in Adenovirus and Cytomegalovirus (CMRX)
Lipocine announces first patient
dosed in Phase 1 study in pregnant women of LPCN 1107, potentially the first
oral product for the prevention of preterm birth (LPCN)
GlycoMimetics announces that data
from preclinical studies demonstrating the in vivo efficacy of GMI-1051 will be
presented at the 28th Annual North American Cystic Fibrosis Conference on
October 9-11 (GLYC)
RJET airways report August revenue
passenger miles up 11% vs last year. (RJET)
ACET acquire
ownership of three soft gel ANDA from Par pharma (ACET)
Korn/Ferry beats by $0.03, reports
revs in-line; guides Q2 EPS in-line, revs below consensus (KFY)
Earnings
before market Open:
BKS, FRAN, PTN, TITN
Earnings
after market close:
PANW, IRET, KKD
Earning
Preview:
HD Supply Holdings, Inc. ( HDS ) is reporting for the quarter ending July 31,
2014. The industrial services company's consensus earnings per share forecast
from the 11 analysts that follow the stock is $0.47. This value represents a
104.35% increase compared to the same quarter last year. HDS missed the
consensus earnings per share in the 3rd calendar quarter of 2013 by -28.12%.
Barnes & Noble, Inc. ( BKS ) is reporting for the quarter ending July 31, 2014. The retail company's consensus earnings per share forecast from the 3 analysts that follow the stock is $-0.68. This value represents a 20.93% increase compared to the same quarter last year. BKS missed the consensus earnings per share in the 2nd calendar quarter of 2014 by -14.29%. The "days to cover" for this stock exceeds 13 days.
No comments:
Post a Comment